Andexanet alfa (Andexxa) made its quiet exit from the U.S. market just a few weeks ago. It's an interesting story so in case you missed it, I'll recap what andexanet alfa is, or rather was, and what happened that led to its removal. Being pulled from the U.S. market may have come to a surprise for some considering its main study (ANNEXA-I) was stopped early for successfully meeting its main efficacy outcome. While having a trial stopped early for superior efficacy results sounds good on the surface, it can have negative ramifications on other aspects of the clinical inquiry (explained below).
Internal Medicine Pharmacotherapy
HughesMedicine - Pharmacotherapy Pearls from the Internal Medicine Clinical Pharmacist
Tuesday, January 20, 2026
Goodbye to Andexanet Alfa (AndexxaⓇ)
Andexanet alfa (Andexxa) made its quiet exit from the U.S. market just a few weeks ago. It's an interesting story so in case you missed it, I'll recap what andexanet alfa is, or rather was, and what happened that led to its removal. Being pulled from the U.S. market may have come to a surprise for some considering its main study (ANNEXA-I) was stopped early for successfully meeting its main efficacy outcome. While having a trial stopped early for superior efficacy results sounds good on the surface, it can have negative ramifications on other aspects of the clinical inquiry (explained below).
Thursday, December 18, 2025
Treating Insomnia in Older Adults: Doxepin Highlights
The American Geriatrics Society recently published their Alternative Treatments to Selected Medications in reference to the most recent update to the AGS Beers Criteria in 2023. This guidance is helpful because while the 2023 AGS Beers Criteria warned about which medications were "potentially inappropriate" in older adults, they left clinicians guessing by not offering suggestions as to which medications should alternatively be used.
Thursday, July 18, 2024
Dyspnea Associated with Ticagrelor
Ticagrelor is an antiplatelet medication that is commonly used for a number of cardiovascular conditions. Its mechanism is similar to that of antiplatelet medications clopidogrel and prasugrel in that it inhibits P2Y12 ADP receptors on platelets, preventing platelet activation and aggregation. Ticagrelor is different from clopidogrel and prasugrel in that it binds reversibly to the receptor and, importantly, it is administered as the active compound. This contrasts with clopidogrel and prasugrel which require metabolic activation by CYP450 enzymes and are therefore susceptible to drug interactions and altered activation in those with polymorphic CYP450 phenotypes (clopidogrel requires two CYP450 enzyme steps for
Monday, March 11, 2024
Thiamine deficiency and supplementation in heart failure
Thiamine is a water-soluble vitamin that is an important coenzyme for various metabolic processes in the body. These include the regulation of glucose metabolism, the Krebs cycle (generates ATP), the pentose shunt (generates NADPH), and maintenance of sodium/potassium gradients in the brain (necessary for conducting nerve impulses). Thiamine is mostly obtained from dietary intake with absorption occurring in the jejunum and ileum. After traveling to the liver, thiamine spends a relatively short amount of time in the blood before distributing to tissues throughout
Tuesday, October 3, 2023
Beers Criteria Update 2023 - Seven Changes
The American Geriatrics Society (AGS) 2023 updated AGS Beers Criteria® for potentially inappropriate medication (PIM) use in older adults was released during the AGS annual meeting in May 2023. This is the sixth update to the criteria which are currently designed to identify potentially inappropriate medications (PIMs) that are best avoided in older adults in general or in specific circumstances. The criteria were first intended to be applied to the nursing home population but were expanded to apply to all adults 65 years old and older (except for end-of-life settings).
Monday, October 22, 2018
Sulfamethoxazole/trimethoprim and increase in serum creatinine: When to be concerned
Recommended for you
-
Let’s start with a patient case. A patient is being treated with methylprednisolone 20 mg IV q6 hours for some inflammatory process and...
-
Andexanet alfa (Andexxa) made its quiet exit from the U.S. market just a few weeks ago. It's an interesting story so in case you missed...
-
A 55 year old business executive is being discharged from the hospital after a brief admission for cellulitis. His only PMH is HTN and o...
-
Since July is here and the academic calendar is starting over, it is time for new medical residents to be arriving to the hospital floors...
-
Let’s start with a patient scenario. A patient presents to the emergency room experiencing a heart failure exacerbation. When entering th...
-
An elderly male presents to the emergency department with complaints of nausea, vomiting, and diarrhea starting a day and a half ago. The...
-
A 65 year old male is being treated for an infection on his forearm that developed purulent drainage within the last few days. He denies ...
-
A 48 year old male is admitted to the hospital after experiencing a fever and malaise for several days. He states that he has some shortn...
-
Thrombocytopenia is a notable adverse effect of linezolid. Some of the evidence behind the onset, duration, and the extent of platelet de...
-
There are many different insulin preparations and supplies available in order to create individualized regimens for patients. Here are s...





